BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1064 related articles for article (PubMed ID: 15831827)

  • 1. Metallo-beta-lactamases: the quiet before the storm?
    Walsh TR; Toleman MA; Poirel L; Nordmann P
    Clin Microbiol Rev; 2005 Apr; 18(2):306-25. PubMed ID: 15831827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
    Walsh TR
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():2-9. PubMed ID: 16209700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallo-β-lactamases: a last frontier for β-lactams?
    Cornaglia G; Giamarellou H; Rossolini GM
    Lancet Infect Dis; 2011 May; 11(5):381-93. PubMed ID: 21530894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMP-type metallo-β-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons.
    Zhao WH; Hu ZQ
    Crit Rev Microbiol; 2011 Aug; 37(3):214-26. PubMed ID: 21707466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
    Rossolini GM; Luzzaro F; Migliavacca R; Mugnaioli C; Pini B; De Luca F; Perilli M; Pollini S; Spalla M; Amicosante G; Toniolo A; Pagani L
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4023-9. PubMed ID: 18809945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired metallo-β-lactamases and their genetic association with class 1 integrons and ISCR elements in Gram-negative bacteria.
    Zhao WH; Hu ZQ
    Future Microbiol; 2015; 10(5):873-87. PubMed ID: 26000655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli.
    Zhao WH; Hu ZQ
    Future Microbiol; 2011 Mar; 6(3):317-33. PubMed ID: 21449842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
    Pfeifer Y; Cullik A; Witte W
    Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.
    Bradford PA
    Clin Microbiol Rev; 2001 Oct; 14(4):933-51, table of contents. PubMed ID: 11585791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minor extended-spectrum beta-lactamases.
    Naas T; Poirel L; Nordmann P
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():42-52. PubMed ID: 18154527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenemases: molecular diversity and clinical consequences.
    Poirel L; Pitout JD; Nordmann P
    Future Microbiol; 2007 Oct; 2(5):501-12. PubMed ID: 17927473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia.
    Peleg AY; Franklin C; Bell JM; Spelman DW
    Clin Infect Dis; 2005 Dec; 41(11):1549-56. PubMed ID: 16267725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired metallo-beta-lactamases: an increasing clinical threat.
    Rossolini GM
    Clin Infect Dis; 2005 Dec; 41(11):1557-8. PubMed ID: 16267726
    [No Abstract]   [Full Text] [Related]  

  • 15. Metallo-beta-lactamases of Pseudomonas aeruginosa--a novel mechanism resistance to beta-lactam antibiotics.
    Sacha P; Wieczorek P; Hauschild T; Zórawski M; Olszańska D; Tryniszewska E
    Folia Histochem Cytobiol; 2008; 46(2):137-42. PubMed ID: 18519228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of co-expression of newer beta-lactamases (ESBLs, Amp-C-beta-lactamases, and metallo-beta-lactamases) in gram-negative bacilli.
    Chatterjee SS; Karmacharya R; Madhup SK; Gautam V; Das A; Ray P
    Indian J Med Microbiol; 2010; 28(3):267-8. PubMed ID: 20644325
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
    Shah AA; Hasan F; Ahmed S; Hameed A
    Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory.
    Kim SY; Hong SG; Moland ES; Thomson KS
    J Clin Microbiol; 2007 Sep; 45(9):2798-801. PubMed ID: 17596358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [News of antibiotic resistance among Gram-negative bacilli in Algeria].
    Baba Ahmed-Kazi Tani Z; Arlet G
    Pathol Biol (Paris); 2014 Jun; 62(3):169-78. PubMed ID: 24819127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria.
    Bush K; Fisher JF
    Annu Rev Microbiol; 2011; 65():455-78. PubMed ID: 21740228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.